Literature DB >> 19272548

Impact of bedside open lung biopsies on the management of mechanically ventilated immunocompromised patients with acute respiratory distress syndrome of unknown etiology.

Emmanuel Charbonney1, John Robert, Jean-Claude Pache, Jean-Claude Chevrolet, Philippe Eggimann.   

Abstract

BACKGROUND: Open lung biopsy (OLB) is helpful in the management of patients with acute respiratory distress syndrome (ARDS) of unknown etiology. We determine the impact of surgical lung biopsies performed at the bedside on the management of patients with ARDS.
METHODS: We reviewed all consecutive cases of patients with ARDS who underwent a surgical OLB at the bedside in a medical intensive care unit between 1993 and 2005.
RESULTS: Biopsies were performed in 19 patients mechanically ventilated for ARDS of unknown etiology despite extensive diagnostic process and empirical therapeutic trials. Among them, 17 (89%) were immunocompromised and 10 patients experienced hematological malignancies. Surgical biopsies were obtained after a median (25%-75%) mechanical ventilation of 5 (2-11) days; mean (+/-SD) Pao(2)/Fio(2) ratio was 119.3 (+/-34.2) mm Hg. Histologic diagnoses were obtained in all cases and were specific in 13 patients (68%), including 9 (47%) not previously suspected. Immediate complications (26%) were local (pneumothorax, minimal bleeding) without general or respiratory consequences. The biopsy resulted in major changes in management in 17 patients (89%). It contributed to a decision to limit care in 12 of 17 patients who died.
CONCLUSION: Our data confirm that surgical OLB may have an important impact on the management of patients with ARDS of unknown etiology after extensive diagnostic process. The procedure can be performed at the bedside, is safe, and has a high diagnostic yield leading to major changes in management, including withdrawal of vital support, in the majority of patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19272548     DOI: 10.1016/j.jcrc.2008.01.008

Source DB:  PubMed          Journal:  J Crit Care        ISSN: 0883-9441            Impact factor:   3.425


  10 in total

1.  The diagnostic yield and complications of open lung biopsies in kidney transplant patients with pulmonary disease.

Authors:  Daniere Yurie Vieira Tomotani; Antônio Tonete Bafi; Eduardo Souza Pacheco; Tainá Veras de Sandes-Freitas; Laila Almeida Viana; Edgar Porto de Oliveira Pontes; Nikkei Tamura; Hélio Tedesco-Silva; Flavia Ribeiro Machado; Flávio Geraldo Rezende Freitas
Journal:  J Thorac Dis       Date:  2017-01       Impact factor: 2.895

2.  Open lung biopsy in nonresolving ARDS frequently identifies diffuse alveolar damage regardless of the severity stage and may have implications for patient management.

Authors:  Claude Guerin; Frédérique Bayle; Véronique Leray; Sophie Debord; Alina Stoian; Hodane Yonis; Jean-Baptiste Roudaut; Gael Bourdin; Mojgan Devouassoux-Shisheboran; Elodie Bucher; Louis Ayzac; Sylvie Lantuejoul; Carole Philipponnet; Jean Louis Kemeny; Bertrand Souweine; Jean-Christophe Richard
Journal:  Intensive Care Med       Date:  2014-12-05       Impact factor: 17.440

3.  ARDS Clinical Practice Guideline 2021.

Authors:  Sadatomo Tasaka; Shinichiro Ohshimo; Muneyuki Takeuchi; Hideto Yasuda; Kazuya Ichikado; Kenji Tsushima; Moritoki Egi; Satoru Hashimoto; Nobuaki Shime; Osamu Saito; Shotaro Matsumoto; Eishu Nango; Yohei Okada; Kenichiro Hayashi; Masaaki Sakuraya; Mikio Nakajima; Satoshi Okamori; Shinya Miura; Tatsuma Fukuda; Tadashi Ishihara; Tetsuro Kamo; Tomoaki Yatabe; Yasuhiro Norisue; Yoshitaka Aoki; Yusuke Iizuka; Yutaka Kondo; Chihiro Narita; Daisuke Kawakami; Hiromu Okano; Jun Takeshita; Keisuke Anan; Satoru Robert Okazaki; Shunsuke Taito; Takuya Hayashi; Takuya Mayumi; Takero Terayama; Yoshifumi Kubota; Yoshinobu Abe; Yudai Iwasaki; Yuki Kishihara; Jun Kataoka; Tetsuro Nishimura; Hiroshi Yonekura; Koichi Ando; Takuo Yoshida; Tomoyuki Masuyama; Masamitsu Sanui
Journal:  J Intensive Care       Date:  2022-07-08

4.  Diffuse alveolar damage of the lungs in forensic autopsies: assessment of histopathological stages and causes of death.

Authors:  Halide Nur Urer; Gokhan Ersoy; Emine Dilek Yılmazbayhan
Journal:  ScientificWorldJournal       Date:  2012-09-17

5.  Histopathologic heterogeneity of acute respiratory distress syndrome revealed by surgical lung biopsy and its clinical implications.

Authors:  Jimyung Park; Yeon Joo Lee; Jinwoo Lee; Sung Soo Park; Young-Jae Cho; Sang-Min Lee; Young Whan Kim; Sung Koo Han; Chul-Gyu Yoo
Journal:  Korean J Intern Med       Date:  2017-11-01       Impact factor: 2.884

6.  Diagnostic yield and therapeutic impact of open lung biopsy in the critically ill patient.

Authors:  Carole Philipponnet; Lucie Cassagnes; Bruno Pereira; Jean-Louis Kemeny; Mojgan Devouassoux-Shisheboran; Alexandre Lautrette; Claude Guerin; Bertrand Souweine
Journal:  PLoS One       Date:  2018-05-25       Impact factor: 3.240

7.  Complications of a lung biopsy for severe respiratory failure: A systematic review and meta-analysis.

Authors:  Hiroshi Sugimoto; Yosuke Fukuda; Yoshie Yamada; Hiroyuki Ito; Takeshi Tanaka; Takuo Yoshida; Satoshi Okamori; Koichi Ando; Yohei Okada
Journal:  Respir Investig       Date:  2022-09-23

8.  The Role of Open Lung Biopsy in Critically Ill Patients with Hypoxic Respiratory Failure: A Retrospective Cohort Study.

Authors:  Abdullah Almotairi; Sharmistha Biswas; Jason Shahin
Journal:  Can Respir J       Date:  2016-05-04       Impact factor: 2.409

9.  Predictors of diffuse alveolar damage in patients with acute respiratory distress syndrome: a retrospective analysis of clinical autopsies.

Authors:  Arnaud W Thille; Oscar Peñuelas; José A Lorente; Pilar Fernández-Segoviano; José-Maria Rodriguez; José-Antonio Aramburu; Julian Panizo; Andres Esteban; Fernando Frutos-Vivar
Journal:  Crit Care       Date:  2017-10-20       Impact factor: 9.097

Review 10.  Acute respiratory distress syndrome.

Authors:  Rob Mac Sweeney; Daniel F McAuley
Journal:  Lancet       Date:  2016-04-28       Impact factor: 79.321

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.